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Abstract
Background: During resuscitation in severe sepsis and septic shock, several goals are set. However, usually not all
goals are equally met. The aim of this study is to determine the relative importance of the different goals, such as
mean arterial pressure (MAP), lactate, central venous oxygen saturation (ScvO2) and central to forefoot temperature
(delta-T), and how they relate to intensive care unit (ICU) and hospital mortality.
Methods: In a retrospective cohort study in a 20-bed mixed medical and surgical ICU of a teaching hospital we
studied consecutive critically ill patients who were admitted for confirmed infection and severe sepsis or septic
shock between 2008 and 2014. All validated MAP, lactate levels, ScvO2 and delta-T for the first 24 hours of ICU
treatment were extracted from a clinical database. Logistic regression analyses were performed on validated
measurements in the first hour after admission and on mean values over 24 hours. Patients were categorized by
MAP (24-hour mean below or above 65 mmHg) and lactate (24-hour mean below or above 2 mmol/l) for Cox
regression analysis.
Results: From 837 patients, 821 were eligible for analysis. All had MAP and lactate measurements. The delta-T was
available in 812 (99 %) and ScvO2 was available for 193 out of these patients (23.5 %). Admission lactate (p < 0.001)
and admission MAP (p < 0.001) were independent predictors of ICU and hospital mortality. The 24-hour mean
values for lactate, MAP and delta-T were all independent predictors of ICU mortality. Hospital mortality was
independently predicted by the 24-hour mean lactate (odds ratio (OR) 1.34, 95 % confidence interval (CI) 1.30–1.40,
p = 0.001) mean MAP (OR 0.96, 95 % CI 0.95–0.97, p = 0.001) and mean delta-T (OR 1.09, 95 % CI 1.06–1.12, p = 0.001).
Patients with a 24-hour mean lactate below 2 mmol/l and a 24-hour mean MAP above 65 mmHg had the best
survival, followed by patients with a low lactate and a low MAP.
Conclusions: Admission MAP and lactate independently predicted ICU and hospital mortality. The 24-hour mean
lactate, mean MAP and mean delta-T independently predicted hospital mortality. A Cox regression analysis showed
that 24-hour mean lactate above 2 mmol/l is the strongest predictor for ICU mortality.
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Background
Intensive care clinicians use several concomitant resusci-
tation goals to guide their treatment, such as arterial and
venous pressure, cardiac output, central venous oxygen
saturation (ScvO2) and serum lactate levels. The Surviv-
ing Sepsis Campaign (SSC) guideline is in use worldwide
and provides clinicians with clear recommendations on
mean arterial pressure (MAP), ScvO2 and lactate levels
[1]. The targeted MAP of at least 65 mmHg in the SSC
guideline has been recently challenged by several studies
[2–7]. Some studies do not show improved outcome
when a higher blood pressure is achieved [2], but other
studies show that a lower mean blood pressure of 50–60
mmHg is associated with a higher incidence of renal fail-
ure [3]. For the serum lactate level it is recommended to
target normal levels [1]. A lactate level below 4 mmol/l
is usually considered acceptable. However, levels in the
normal range (below 2 mmol/l) may be associated with
better outcomes [8–10]. In addition, it is unclear whether
targeting the microcirculation should be a resuscitation
goal as well [11, 12]. As a proxy for the microcirculation,
the central to toe temperature difference is sometimes
used [13, 14].
In the clinical setting a discrepancy between different
resuscitation goals sometimes arises where, for instance,
either lactate or MAP is abnormal. It is unclear whether
all resuscitation goals are equally related to mortality or
whether one of them may need more attention than the
other. The aim of this study is to gain insight into the
association of several resuscitation targets with mortal-
ity. We performed a retrospective analysis of several re-
suscitation goals over the first 24 hours in critically ill
patients admitted for severe sepsis or septic shock, and
related them to outcome.
Methods
Patients
Consecutive critically ill patients were included in a
retrospective cohort study over the period January 2008
till January 2014. Patients were included when they were
aged 18 years or older, and when they had a confirmed
infection on admission and one or more organ failures.
To prevent the inclusion of elective surgery patients, we
excluded patients with planned admissions. Patients
were also excluded when a recent myocardial infarction,
chronic renal insufficiency or liver cirrhosis was present.
In addition, pregnant patients and patients after cardiac
surgery were excluded. Patients were excluded for ana-
lysis when no lactate measurements were available at all.
Setting and therapeutic management
The study was performed at the intensive care unit of
Onze Lieve Vrouwe Gasthuis (OLVG), a 20-bed mixed
intensive care unit (ICU) of a teaching hospital in
Amsterdam, The Netherlands.
Baseline treatment was unchanged during the study
period and consisted of broad-spectrum antibiotics aim-
ing at the potential source of infection after blood cul-
tures. In addition, surgical source control was achieved
when needed. Fluid resuscitation with crystalloids and
norepinephrine and/or dopamine was given where ap-
propriate to achieve MAP to at least 60 mmHg or to a
level that was deemed appropriate by the attending
physician. Mechanical ventilation was indicated for pa-
tients who were in respiratory distress, at the discretion
of the attending physician. All septic shock patients re-
ceived corticosteroids until shock was reversed, usually a
5-day tapering dose of prednisone from 40 to 0 mg per
day. Feeding was started on admission and glucose regula-
tion was performed with a nurse-driven protocol to main-
tain glucose between 6–9 mmol/l. A hemoglobin target of
7–9 g/dl was held according to Dutch guidelines.
Data collection
Baseline variables such as gender, age, severity of disease
(Acute Physiology and Chronic Health Evaluation (APA-
CHE) IV and Sequential Organ Failure Assessment
(SOFA)) and treatment data such as mechanical ventila-
tion, renal replacement therapy, vasoactive drugs and
fluids were all extracted over the first 24 hours after
admission. The data were stored in the Patient Data
Management System (PDMS; Metavision, iMDSoft, Tel
Aviv, Israel). MAP was measured continuously, but the
nurse validated the data at least once per hour at the
bedside. All validated MAPs were extracted from the
first 24 hours. When invasive arterial pressure measure-
ment was not available, non-invasive measurement was
extracted instead. Patients were categorized according to
MAP below or above 65 mmHg (admission or arith-
metic mean of 24 hours) and shown as MAP(adm) or
MAP(24 h) based on the current guideline [1].
Lactate was routinely measured on admission of all pa-
tients and at every arterial blood gas analysis (Radiom-
eter, Copenhagen, Denmark). All lactate measurements
for the first 24 hours after admission were extracted
from the PDMS. Lactate values are shown as admission
lactate (lactate(adm)) and as the arithmetic mean of all
available measurements over the first 24 hours of ICU
stay (lactate(24 h)). Patients were categorized according
to lactate(adm) or lactate(24 h) below or above 2 mmol/
l. Temperature was routinely measured centrally and on
the forefoot to obtain a change in temperature (delta-T)
between the central and peripheral location. All available
delta-T for the first 24 hours after admission were ex-
tracted from the PDMS and shown as admission meas-
urement (delta-T(adm)) and as arithmetic mean of all
validated measurements during the first 24 hours after
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admission (delta-T(24 h)). ScvO2 was not routinely mea-
sured on admission; data are shown as arithmetic mean of
the 24-hour data (ScvO2(24 h)). The time between mea-
surements was not taken into account when calculating
the arithmetic mean for MAP, lactate, ScvO2 and delta-T.
Ethical statement
The local Medical Ethical Committee of the Onze Lieve
Vrouwe Gasthuis approved the study. The need for in-
formed consent was waived because of the retrospective
and observational design of the study according to Dutch
and European legislation.
Statistical analysis
Three analyses were made according to a predefined
analysis plan: 1) using the admission data within the first
hour in the ICU, marked as (adm); 2) calculated mean
values over the first 24-hour period in the ICU, marked
as (24 h); and 3) according to four groups with either
MAP(24 h) below or above 65 mmHg and lactate(24 h)
above or below 2 mmol/l.
One database contained the original data and additional
databases contained the results of multiple imputations
for missing values. The Markov Chain Monte Carlo
method (MCMC) for multiple imputation technique was
used to obtain these missing data [15]. Multiple imput-
ation was performed for MAP(adm), which was missing
in 4.9 % of patients, delta-T(adm), which was missing in
34.6 % of patients, and lactate(adm) which was missing in
16 % of the patients. Baseline variables are described as
mean with standard deviation (SD) for variables with a
normal distribution. All other variables are shown as
median with interquartile range (IQR). Normality was
checked by Q-Q plot analyses and skewness and kurtosis
tests for normality. Groups were compared with paramet-
ric or non-parametric tests where applicable. Nominal
variables were tested with Fisher exact test, and continu-
ous variables with the non-parametric Kruskal-Wallis test.
All analyses were tested two-sided with a significance level
of 0.05. Univariate analyses were made for all variables but
multivariate regression analyses were performed with
MAP, lactate, and delta-T only because we did not aim to
develop an overall prediction model. However, additional
backward conditional regression analyses were performed
on the model to test the effect of APACHE IV predicted
mortality as a measurement of severity of disease as well
as with noradrenaline and dopamine dose and fluid bal-
ance. ScvO2 was not included in the logistic analysis be-
cause of the large number of missing data. Multivariate
logistic regression analyses with the imputed variables
were used to test MAP, lactate and delta-T as independent
variables and both hospital and ICU mortality, respect-
ively, as dependent variables. The independent variables
were all entered in block 1. These regression analyses were
performed with data (adm) and (24 h). Because of the
large numbers of missing ScvO2 data we performed the
analyses without ScvO2. To study the effect of time, the
consecutive ICU numbers of the patients were entered as
well. Multicollinearity of the variables was excluded by
correlation check (all correlation coefficients appeared
below 0.4). Effect modification was excluded by analysis of
interaction terms. Hosmer-Lemeshow goodness of fit and
receiver operator characteristic curve (ROC) analyses were
made for each regression analysis.
A Cox regression analysis was performed with the four
groups based on lactate(24 h) (above or below 2 mmol/l)
and MAP(24 h) (above or below 65 mmHg) and length
of ICU stay as the dependent value. The lactate threshold
of 2 mmol/l was chosen because of the current literature
on the relation between lactate and mortality [8–10]. The
threshold for MAP was chosen because of current guide-
lines [1]. All statistical analyses were made using Statistical
Package for Social Science (SPSS 21.0 Chicago, IL, USA).
Results
A total of 837 consecutive patients were included. Lac-
tate measurements were absent in 16 patients, and thus
821 patients were eligible for analysis. The total number
of lactate measurements was 3538 in 638 patients (mean
5.45 measurements per patient) for patients with a MAP
above 65 mmHg vs. 1096 measurements in 183 patients
(mean 5.98 per patient) with blood pressure below 65
mmHg. In these patients the delta-T was available in
812 (99 %) and ScvO2 was available for 193 out of the
821 patients (23.5 %).
Table 1 shows the baseline characteristics of all in-
cluded patients. In addition, the characteristics of the
four distinct categories based on MAP(24 h) and lac-
tate(24 h) are shown. The hospital mortality was highest
(53.9 %) when lactate(24 h) was above 2 mmol/l and
MAP(24 h) below 65 mmHg and mortality was lowest
when lactate(24 h) was low and MAP(24 h) was high
(15.8 %) (Table 1).
Admission measurements
Lactate(adm) was missing in 132 of 821 (16 %) patients,
MAP(adm) was missing in 40 of 821 (4.9 %) patients,
delta-T(adm) was missing in 284 of 821 (34.6 %) patients
and ScvO2 was missing in 789 of 821 (96 %) patients.
The number of patients that had a first measured lac-
tate above 2 mmol/l was 378 patients (46 %). A first
MAP below 65 mmHg was present in 251 patients (31 %).
In these patients, MAP stayed significantly lower over 24
hours compared to patients with a first MAP above 65
mmHg (p < 0.001).
Table 2 shows the univariate analysis on both ICU and
hospital mortality. Lactate(adm), MAP(adm) and
ScvO2(adm) were associated with mortality but delta-
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Table 1 Baseline characteristics of included patients
All N = 821 Lactate(24 h) <2 mmol/l Lactate(24 h) <2 mmol/l Lactate(24 h) ≥2 mmol/l Lactate(24 h) ≥2 mmol/l p
value*MAP(24 h) <65 mmHg MAP(24 h) ≥65 mmHg MAP(24 h) <65 mmHg MAP(24 h) ≥65 mmHg
N = 68 N = 406 N = 115 N = 232
Male (%) 532/821 (64.8) 45/68 (66.2) 274/406 (67.5) 77/115 (67.0) 136/232 (58.6) 0.15
Age (years) 64.0 (14.4) 68.7 (12.1) 62.8 (14.4) 68.2 (11.3) 62.5 (15.8) 0.001
MAP(adm) 76.9 (21) 64.8 (14) 83.2 (21) 62.6 (14) 76.5 (22) 0.001
MAP(24 h) 72.7 (10) 61.6 (2.9) 77.3 (9.4) 60.2 (4.4) 73.9 (8.1) 0.001
Lactate(adm) 1.9 (1.2–3.5) 1.3 (1.1–1.9) 1.3 (1.0–1.7) 4.2 (2.7–6.6) 3.5 (2.6–5.2) 0.001
Lactate(24 h) 1.8 (1.2–2.8) 1.3 (1.1–1.8) 1.3 (1.1–1.6) 3.9 (2.7–6.2) 2.9 (2.3–4.1) 0.001
ScvO2(adm) 66.4 (11) 76.4 (3.3) 68.3 (9.0) 63.9 (11) 64.7 (13) 0.50
ScvO2(24 h) 69.3 (9.4) 71.1 (11) 71.3 (8.6) 68.4 (7.6) 67.3 (9.9) 0.063
Delta-T(adm) 6.6 (4.2–9.3) 7.2 (3.2–10) 5.9 (3.9–8.8) 7.4 (5.1–9.7) 7.4 (4.8–9.9) 0.007
Delta-T(24 h) 3.7 (2.8–5.1) 3.4 (2.7–4.9) 3.3 (2.5–4.5) 4.5 (3.3–6.1) 4.0 (3.1–5.8) 0.001
24-h fluid balance (ml) 3366 (1314–5568) 4321 (2160–5939) 2238 (825–3973) 7080 (3671–9795) 3932 1722–6277) 0.001
Mechanical ventilation (%) at any time during ICU stay 627/821 (76) 52/68 (76.5) 304/406 (74.9) 95/115 (82.6) 176/232 (75.9) 0.39
P/F ratio (lowest during ICU stay) 156 (105–226) 169 (117–232) 160 (107–220) 140 (89–202) 166 (105–257) 0.04
Noradrenalin dosea (mg) 0.0 (0–4.2) 0.57 (0–4.8) 0.0 (0–0.85) 7.4 (0.98-19.2) 0.72 (0–6.9) 0.001
Dopamine dosea (mg) 215 (59–469) 402 (230–727) 172 (0–320) 515 (231–912) 219 (62–473) 0.001
History of arterial hypertension 237/821 (28.9) 18/68 (26.5) 131/406 (32.3) 34/115 (29.6) 54/232 (23.3) 0.11
CRRTb (%) 121/821 (14.7) 12/68 (17.6) 22/406 (5.4) 49/115 (42.6) 38/232 (16.4) 0.001
SOFA admission 7.8 (3.7) 8.1 (3.2) 6.5 (2.7) 10.9 (4.5) 8.7 (3.8) 0.001
APACHE IV predicted mortality 0.34 (0.16–0.60) 0.37 (0.19–0.57) 0.25 (0.13–0.45) 0.63 (0.37–0.84) 0.37 (0.18–0.67) 0.001
Length of ICU stay in hours 86.0 (40.0–209) 96.5 (47.8–254) 72 (39.0–189) 120 (64.0–283) 80.5 (36.0–199) 0.013
ICU mortality (%) 146/821 (17.8) 13/68 (19.1) 37/406 (9.1) 51/115 (44.3) 45/232 (19.4) 0.001
Hospital mortality (%) 215/821 (26.2) 18/68 (26.5) 64/406 (15.8) 62/115 (53.9) 71/232 (30.6) 0.001
Values for MAP are given in mmHg, values for lactate in mmol/l, values delta-T in °C and values for ScvO2 in %
Groups represent mean lactate and mean MAP over the first 24 hours of ICU admission. Data are given as mean (standard deviation) or median (interquartile range)
*p-value shows differences between all groups
a Cumulative dose over first 24 hours of ICU admission
b At any time during ICU admission, available for 193 patients
(24 h) arithmetic mean of all validated measurements during the first 24 hours after admission, (adm) at admission, APACHE Acute Physiology and Chronic Health Evaluation, CRRT continuous renal replacement












T(adm) was not. Because of the limited number of
ScvO2 measurement on admission, ScvO2 was not in-
cluded in the multiple regression analysis using admis-
sion data. Table 3 shows that, in the multiple regression
analysis, MAP(adm) and lactate(adm) are independently
associated with ICU and hospital mortality. Lactate was
the strongest predictor as shown by the highest Wald
score and highest coefficient. The model fits reasonably
well for ICU mortality with a Hosmer-Lemeshow good-
ness of fit (Chi-square, 13; p = 0.10) and ROC area under
the curve (AUC) of 0.60. For the hospital mortality, the
Hosmer-Lemeshow goodness of fit showed a Chi-square
of 23 (p = 0.003) and ROC-AUC of 0.64.
Twenty-four-hour mean values
The univariate analysis (Table 2) showed that all vari-
ables were associated with ICU and hospital mortality.
Because of the large number of missing values, ScvO2
was not included in the consecutive multivariate logistic
regression analysis. Twenty-four-hour mean MAP, mean
lactate and mean delta-T were entered as independent
variables. We show that all three variables were inde-
pendently related to ICU mortality (Hosmer-Lemeshow
goodness of fit Chi-square 98 (p = 0.001) and ROC-AUC
0.71) and with hospital mortality (Hosmer-Lemeshow
goodness of fit Chi-square 48 (p = 0.001) and ROC-AUC
0.68; Table 4). Lactate appeared to be the strongest pre-
dictor with the highest Wald score and highest coeffi-
cient (Table 4). A repeated analysis including the ScvO2
data (N = 193) showed that lactate(24 h) was the only in-
dependent variable for hospital mortality. APACHE IV
significantly predicted hospital mortality (p = 0.001).
Therefore, we added APACHE IV as a marker for sever-
ity of disease in the logistic model but this did not
change the relation between the independent variables
and hospital mortality (data not shown). Fluid balance,
noradrenaline dose and dopamine dose were significantly
related to ICU and hospital mortality in a univariate ana-
lysis, but in the logistic regression model they were not
and were therefore excluded in the backward regression
for the final model. We also analyzed the influence of
admission chronology by entering the consecutive ICU
numbers of the patients, but could not find any relation
with outcome.
Further analysis of the relative importance of MAP
and lactate by a Cox regression prediction model (Fig. 1)
shows that MAP(24 h) above 65 mmHg and lactate(24 h)
below 2 mmol/l is associated with the lowest mortality
and a MAP(24 h) below 65 mmHg and a lactate(24 h)
Table 2 Univariate analysis of circulatory variables on admission
and 24-hour means
ICU mortality Hospital mortality
Lactate(adm) 1.2 (1.17–1.23) 1.2 (1.17–1.22)
Lactate(24 h) 1.45 (1.39–1.50) 1.45 (1.4–1.50)
MAP(adm) 0.98 (0.98–0.99) 0.986 (0.986–0.991)
MAP(24 h) 0.92 (0.91–93) 0.94 (0.93–0.95)
ScvO2(adm) 1.04 (1.0–1.07) 1.0 (0.98–1.04)
ScvO2(24 h) 1.03 (1.01–1.05) 1.0 (0.99–1.01)
Delta-T(adm) 0.99 (0.98–1.02) 1.06 (1.04–1.08)
Delta-T(24 h) 1.21 (1.17–1.25) 1.17 (1.13–1.20)
Fluid balance(24 h) 1.00 (1.00–1.00) 1.00 (1.00–1.00)
Dopamine dose(24 h) 1.002 (1.001–1.002) 1.001 (1.001–1.002)
Noradrenaline dose(24 h) 1.03 (1.02–1.04) 1.03 (1.02–1.04)
Values are shown as odds ratios (95 % confidence interval)
(24 h) arithmetic mean of all validated measurements during the first 24 hours
after admission, (adm) at admission, delta-T difference between central and
forefoot temperature, ICU intensive care unit, MAP mean arterial pressure,
ScvO2 central venous oxygen saturation
Table 3 Logistic regression analysis for admission values of
MAP, lactate and delta-T
Coefficient Wald OR (95 % CI) p value
ICU mortality
MAP(adm) −0.012 54 0.988 (0.985–0.991) 0.001
Lactate(adm) 0.162 173 1.17 (1.15–1.21) 0.001
Delta-T(adm) −0.07 0.57 0.993 (0.976–1.01) 0.45
Constant −1.15 72 0.317 0.001
Hospital mortality
MAP(adm) −0.008 32 0.992 (0.989–0.995) 0.001
Lactate(adm) 0.159 177 1.17 (1.15–1.20) 0.001
Delta-T(adm) −0.002 0.083 0.998 (0.983–1.01) 0.77
Constant −0.894 54 0.409 0.001
(adm) at admission, CI confidence interval, delta-T difference between central
and forefoot temperature, ICU intensive care unit, OR odds ratio, MAP mean
arterial pressure
Table 4 Multivariate logistic regression analysis for mean 24-hour
measurements
Coefficient Wald OR (95 % CI) p value
ICU mortality
MAP(24 h) −0.056 121 0.95 (0.94–0.96) 0.001
Lactate(24 h) 0.28 227 1.32 (1.28–1.37) 0.001
Delta-T(24 h) 0.125 54 1.13 (1.10–1.17) 0.001
Constant 1.06 7.8 2.89 0.005
Hospital mortality
MAP(24 h) −0.04 98 0.96 (0.95–0.97) 0.001
Lactate(24 h) 0.30 245 1.34 (1.30–1.40) 0.001
Delta-T(24 h) 0.085 29.9 1.09 (1.06–1.12) 0.001
Constant 0.685 4.8 1.98 0.03
(24 h) arithmetic mean of all validated measurements during the first 24 hours
after admission, CI confidence interval, delta-T difference between central and
forefoot temperature, ICU intensive care unit, OR odds ratio, MAP mean
arterial pressure
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above 2 mmol/l is associated with the highest mortality.
The two groups with mean 24-hour lactate levels lower
than 2 mmol/l had the best survival during ICU stay.
Discussion
In this retrospective cohort study including 821 patients
with severe sepsis and septic shock we show that both
lactate and MAP are, in a multivariate analysis, inde-
pendently related to ICU and hospital mortality in critic-
ally ill patients admitted with severe sepsis or septic
shock. Lactate appeared to be the strongest predictor
based on the regression coefficients and Wald score. In
addition, the Cox regression model shows that the two
groups with a low 24-hour mean lactate have the best
survival over time. These results suggest that the clinical
relevance of lactate, as a resuscitation goal, is of greater
importance than MAP. In addition, the present study
shows that mean 24-hour delta-T is related to ICU and
hospital mortality but that mean ScvO2 is not. The num-
ber of missing ScvO2 measurements was high and may
have contributed to this result. These findings are in
concordance with Hernandez et al. who showed that
only hyperlactatemia was associated with mortality
[12, 16], and with the recent analysis of data from
the SSC [17]. Our findings add to this knowledge by
showing the relatively great importance of lactate in
comparison to blood pressure. It was previously shown
that patients with a clinically suspected infection and with
a lactate value greater than 4 mmol/l in the presence of
hypotension had an increased risk of in-hospital mortality
[17]. The authors suggest that a trigger for quantitative re-
suscitation should be at a lactate of 4 mmol/l and maybe
even lower at 2 mmol/l. Recent publications on arterial
pressure and sepsis advise to maintain a target MAP of at
least 65 mmHg (Grade 1C, indicating a strong recommen-
dation with a low level of evidence) [1, 18, 19]. However,
the goal for an effective MAP in septic patients is being
challenged since studies that strive for a predefined MAP,
often by using fluids and vasopressors, did not improve
survival [2, 6, 20, 21]. The group of patients with a low lac-
tate and a low MAP needs further study since Hernandez
et al. stated that persistent sepsis-induced hypotension
without hyperlactatemia is associated with less organ dys-
function and a very low mortality risk [16]. In our study
this group has a moderate mortality as shown in the Cox
regression model (Fig. 1). The Cox regression shows that
both groups with low lactate have the best prognosis in
contrast to the two groups with high MAP.
Due to the retrospective study design the results can
only be seen as hypothesis generating. In addition, this
retrospective cohort analysis does not answer the question
whether active treatment of either low blood pressure or
elevated lactate will improve survival. Prospective ran-
domized trials will be needed to answer these questions.
The present data suggest that future studies concerning
resuscitation of patients with severe sepsis and septic
Fig. 1 Cox regression model for ICU survival based on the four categories for mean 24-hour values of lactate and MAP. –2Log-likelihood = 1524;
Chi-sqare 32, p = 0.001 between groups. ICU intensive care unit, MAP mean arterial pressure
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shock may focus more on lactate and less on blood pres-
sure. Early lactate clearance is associated with improved
outcome [22] and a previous study focusing on lactate
normalization indeed showed beneficial effects with de-
creasing mortality from 43.5 % to 33.9 % [23]. However,
which strategies are preferred to reduce lactate levels is
still unclear. Skin mottling was independently associated
with mortality in a previous study. We confirmed the in-
dependent relation of skin temperature with hospital or
ICU mortality in our multivariate analysis [24]. However,
it is unknown if specific strategies to improve skin perfu-
sion will lead to better outcomes.
Our study has several strengths and limitations. This
relatively large cohort had, in the single center design,
for all patients a similar basic treatment based on local
protocols concerning antibiotics, steroids, mechanical
ventilation and feeding. Another strength is the meticu-
lously and prospectively recording of all data as this ICU
has used a highly sophisticated and protocolled database
for 14 years. There still exists a difference in data collec-
tion between MAP, lactate and ScvO2, however. MAP is
precisely validated at least every hour, but lactate is not
routinely measured every hour. As a consequence, when
a patient improves, the number of lactate measurements
will decrease. By calculating the arithmetic mean of the
lactate measurements, we may have overestimated the
mean lactate level over the first 24 hours, but this makes
our conclusion more likely stronger than weaker. We
did not include an analysis of variability of blood pres-
sure or lactate. This was not performed because it would
require a more standardized data collection at precise
time intervals. A limited number of ScvO2 measurements
were available (23.5 %) as not all patients had a jugular or
subclavian central line. Though this is a clinical reality, it
may be true that an analysis with complete hourly ScvO2
measurements may have given other results. The U-
shaped curve of ScvO2 and mortality may play a role as
well. We performed an additional analysis with the limited
ScvO2 data (193 patients). In that analysis lactate was the
only independent predictor for hospital mortality (data
not shown). It may be possible that ScvO2 is of greater im-
portance than is shown in this analysis. Another limitation
of the study is that the groups differ not only in blood
pressure and lactate level but also in the amount of fluids
infused and the use of vasoactive drugs. A large volume of
fluids infused is associated with adverse outcome [25].
Sadaka et al. concluded in their resuscitation study that, in
patients with more than 6 liters within 24 hours, mortality
increased from 42 % to 55–58 %; below 6 liters there are
no major differences to be seen [25]. However, in our
study it is more logical to suppose that the low blood pres-
sure or high lactate was the reason for extra infusion and
vasopressors. We performed an additional regression ana-
lysis with fluid balance and dopamine and noradrenaline
dose (data not shown). We found that these variables were
not independently related to mortality in the multivariate
analysis and were excluded in the backward regression.
Although, because of its retrospective design, individual
resuscitation and circulatory therapy was not standardized
in detail, a local protocol for treatment of sepsis and septic
shock was available in the complete study. Finally, our
study is limited to the first 24 hours after admission to the
ICU, but treatment had already started in the emergency
room where fluids and antibiotics were initiated.
Conclusion
We have shown that lactate level on admission and 24-
hour mean lactate level, as well as MAP on admission
and 24-hour mean MAP are independently related with
outcome. In a multivariate regression analysis, 24-hour
mean lactate, mean MAP and mean delta-T were inde-
pendently related to ICU and hospital mortality but lac-
tate was the strongest predictor. The Cox regression
model suggests that a 24-hour mean lactate level above
2 mmol/l is more strongly associated with hospital mor-
tality than a mean 24-hour MAP below 65 mmHg.
Key messages
 Admission MAP and admission lactate are
associated with mortality but delta-T is not.
 24-hour mean lactate, 24-hour mean MAP and
24-hour mean delta-T are associated with ICU
and hospital mortality
 24-hour mean lactate was the strongest predictor for
ICU and hospital mortality
 The limited number of ScvO2 data hampered final
conclusions concerning ScvO2
 In a Cox regression, 24-hour mean lactate below 2
mmol/l is more strongly associated with hospital
mortality than 24-hour MAP
Abbreviations
APACHE: Acute Physiology and Chronic Health Evaluation; AUC: Area under
the curve; delta-T: Change in temperature between the forefoot and
centrally; delta-T(24 h): Mean delta-T over 24 hours; delta-T(adm): Delta-T at
admission; ICU: Intensive care unit; Lactate(24 h): Mean lactate over 24 hours;
Lactate(adm): Lactate at admission; MAP: Mean arterial pressure; MAP(24
h): Mean arterial pressure over 24 hours; MAP(adm): Mean arterial pressure at
admission; OLVG: Onze Lieve Vrouwe Gasthuis; PDMS: Patient Data
Management System; ROC: Receiver operator characteristic curve;
SSC: Surviving Sepsis Campaign; ScvO2: Central venous oxygen saturation;
ScvO2(24 h): Central venous oxygen saturation over 24 hours.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
APIH performed the basic analyses and drafted the manuscript. SR was
involved in the statistical analysis and in writing the manuscript. RJB
extracted the data from the database and was involved in writing the
manuscript. PHJvdV did the final statistical analysis and editing of the
manuscript. All authors have read and approved the final manuscript.
Houwink et al. Critical Care  (2016) 20:56 Page 7 of 8
Author details
1Department of Intensive Care, OLVG, Amsterdam, The Netherlands.
2Department of Intensive Care, AvL hospital, Amsterdam, The Netherlands.
3TIAS school for Business and Society, Tilburg University, Tilburg, The
Netherlands.
Received: 6 December 2015 Accepted: 15 February 2016
References
1. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign:
international guidelines for management of severe sepsis and septic shock:
2012. Crit Care Med. 2013;41:580–637.
2. Takala J. Should we target blood pressure in sepsis? Crit Care Med. 2010;38:
S613–9.
3. Thooft A, Favory R, Salgado DR, et al. Effects of changes in arterial pressure
on organ perfusion during septic shock. Crit Care. 2011;15:R222.
4. ProCESS Investigators Angus DC, Yealy DM, et al. Protocol-based care for
early septic shock. N Engl J Med. 2014;370:1683–93.
5. Perel A. Bench-to-bedside review: the initial hemodynamic resuscitation of
the septic patient according to Surviving Sepsis Campaign
guidelines—does one size fit all? Crit Care. 2008;12:223.
6. Asfar P, Meziani F, Hamel J-F, et al. High versus low blood-pressure target in
patients with septic shock. N Engl J Med. 2014;370:1583–93.
7. Investigators ARISE, Clinical Trials Group ANZICS, Peake SL, et al. Goal
directed resuscitation for patients with early septic shock. N Engl J Med.
2014;371:1496–506.
8. Napoli AM, Seigel T. The role of lactate clearance in the resuscitation
bundle. Crit Care. 2011;15:199.
9. Nguyen HB, Loomba M, Yang JJ, et al. Early lactate clearance is associated
with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction
and mortality in severe sepsis and septic shock. J Inflamm (Lond). 2010;7:6.
10. Andersen LW, Mackenhauer J, Roberts JC, et al. Etiology and therapeutic
approach to elevated lactate levels. Mayo Clin Proc. 2013;88:1127–40.
11. Dubin A, Pozo MO, Casabella C, et al. Increasing arterial blood pressure with
norepinephrine does not improve microcirculatory blood flow: a
prospective study. Crit Care. 2009;13:R92.
12. Hernandez G, Boerma EC, Dubin A, et al. Severe abnormalities in
microvascular perfused vessel density are associated to organ dysfunctions
and mortality and can be predicted by hyperlactatemia and norepinephrine
requirements in septic shock patients. J Crit Care. 2013;28:538. e9–14.
13. Boerma EC, Kuiper M, Kingma WP, et al. Disparity between skin perfusion
and sublingual microcirculatory alterations in severe sepsis and septic shock: a
prospective observational study. Intensive Care Med. 2008;34:1294–8.
14. Hernandez G, Pedreros C, Veas E, et al. Evolution of peripheral vs metabolic
perfusion parameters during septic shock resuscitation. A clinical-physiologic
study. J Crit Care. 2012;27:283–8.
15. Chevret S, Seaman S, Resche-Rigon M. Multiple imputation: a mature
approach to dealing with missing data. Intensive Care Med. 2015;41:348–50.
16. Hernandez G, Bruhn A, Castro R, et al. Persistent sepsis-induced hypotension
without hyperlactatemia: a distinct clinical and physiological profile within
the spectrum of septic shock. Crit Care Res Pract. 2012;2012:536852.
17. Casserly B, Phillips GS, Schorr C, et al. Lactate measurements in sepsis-
induced tissue hypoperfusion. Crit Care Med. 2015;43:567–73.
18. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign:
international guidelines for management of severe sepsis and septic shock:
2008. Crit Care Med. 2008;36:296–327.
19. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the
treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–77.
20. Dünser MW, Ruokonen E, Pettilä V, et al. Association of arterial blood
pressure and vasopressor load with septic shock mortality: a post hoc
analysis of a multicenter trial. Crit Care. 2009;13:R181.
21. Jones AE, Trzeciak S, Dellinger RP. Arterial pressure optimization in the
treatment of septic shock: a complex puzzle. Crit Care. 2010;14:102.
22. Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated
with improved outcome in severe sepsis and septic shock. Crit Care Med.
2004;32:1637–42.
23. Jansen TC, van Bommel J, Schoonderbeek FJ, et al. Early lactate-guided
therapy in intensive care unit patients: a multicenter, open-label,
randomized controlled trial. Am J Respir Crit Care Med. 2010;182:752–61.
24. Coudroy R, Jamet A, Frat JP, et al. Incidence and impact of skin mottling
over the knee and its duration on outcome in critically ill patients. Intensive
Care Med. 2014;41:452–9.
25. Sadaka F, Juarez M, Naydenov S, et al. Fluid resuscitation in septic shock:
the effect of increasing fluid balance on mortality. J Intensive Care Med.
2014;29:213–7.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Houwink et al. Critical Care  (2016) 20:56 Page 8 of 8
